journal article·2020-04-08

Melanoma Cell Membrane Biomimetic Versatile CuS Nanoprobes for Homologous Targeting Photoacoustic Imaging and Photothermal Chemotherapy

Minliang Wu, Tianxiao Mei, Chenyu Lin, Yuchong Wang, Jingyao Chen, Wenjun Le, Mengyan Sun, Jianguo Xu, Haiying Dai, Yifan Zhang, Chunyu Xue, Zhongmin Liu, Bingdi Chen

ACS Applied Materials & Interfaces· Volume 12· Issue 14
Publisher page

Abstract

Modulating the surface properties of nanoparticles (NPs) is an important approach to accomplish immune escape, prolonged the blood retention time, and enhance the ability of targeted drug delivery. The camouflage of cancer cell membrane onto nanoparticles has been proved to be an ideal approach to enhance active targeting ability of NPs. Herein, we isolated the membrane of melanoma cells to coat doxorubicin (DOX) and indocyanine green (ICG)-loaded hollow copper sulfide NPs (ID-HCuSNP@B16F10) for targeted photothermal therapy, photoacoustic imaging, and chemotherapy. A remarkable in vitro anticancer effect after irradiation and homologous targeting can be observed in B16F10 cells after the treatment of ID-HCuSNP@B16F10. Moreover, ID-HCuSNP@B16F10 exhibits excellent photothermal effect in melanoma animal models and achieves a high tumor ablation rate. This biomimetic system can realize high drug loading efficiency, enhanced targeting ability, and ideal antitumor efficiency.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photoacoustic and Ultrasonic Imaging · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Plastic Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, China

Institute for Regenerative Medicine and Translational Nanomedicine, Shanghai East Hospital, The Institute for Biomedical Engineering & Nano Science, Translational Medical Center for Stem Cell Therapy & Institute for Regenerative Medicine, Tongji University School of Medicine, Shanghai 200092, China

Funding

China Postdoctoral Science Foundation · Science and Technology Commission of Shanghai Municipality · National Natural Science Foundation of China · Shanghai Science and Technology Commission

References (50)

Show source-provided references
1. 10.1038/s41568-019-0154-410.1038/s41568-019-0154-4 ↗
2. 10.1001/jamaoncol.2018.451410.1001/jamaoncol.2018.4514 ↗
3. Matsumura Y. · Cancer Res. · 1986 · 46 · 6387
4. 10.1016/j.biomaterials.2016.03.03910.1016/j.biomaterials.2016.03.039 ↗
5. 10.3390/molecules19122058010.3390/molecules191220580 ↗
6. Kim H. S. · Polymer · 2018 · 10 · 96110.3390/polym10090961 ↗
7. 10.2147/IJN.S17020910.2147/IJN.S170209 ↗
8. Zhang C. · ACS Appl. Mater. Interfaces · 2020 · 910710.1021/acsami.9b23413 ↗
9. 10.1039/C7CS00522A10.1039/C7CS00522A ↗
10. 10.1038/nnano.2013.30210.1038/nnano.2013.302 ↗
11. 10.1021/acsami.9b1451910.1021/acsami.9b14519 ↗
12. 10.1016/j.biomaterials.2017.03.00310.1016/j.biomaterials.2017.03.003 ↗
13. 10.1021/acs.nanolett.7b0529210.1021/acs.nanolett.7b05292 ↗
14. 10.1021/acsami.9b0409810.1021/acsami.9b04098 ↗
15. 10.1021/acsami.9b0686610.1021/acsami.9b06866 ↗
16. 10.1021/acs.accounts.8b0035110.1021/acs.accounts.8b00351 ↗
17. 10.1039/C8CS00618K10.1039/C8CS00618K ↗
18. Miao Q. · Adv. Mater. · 2016 · 28 · 360610.1002/adma.201670129 ↗
19. Paproski R. J. · Small · 2016 · 12 · 37110.1002/smll.201502450 ↗
20. 10.1038/s41467-018-06529-y10.1038/s41467-018-06529-y ↗
21. 10.1021/nn302782y10.1021/nn302782y ↗
22. 10.1002/adma.20130123210.1002/adma.201301232 ↗
23. 10.1021/acsami.9b0621210.1021/acsami.9b06212 ↗
24. 10.1002/smll.20130117410.1002/smll.201301174 ↗
25. 10.1021/acsami.9b0110710.1021/acsami.9b01107 ↗
26. 10.1021/acsnano.6b0576010.1021/acsnano.6b05760 ↗
27. 10.1021/acsnano.7b0835510.1021/acsnano.7b08355 ↗
28. 10.1002/smll.20120078310.1002/smll.201200783 ↗
29. Harris J. · Cancers · 2019 · 11 · 183610.3390/cancers11121836 ↗
30. 10.1039/C1CS15252A10.1039/C1CS15252A ↗
31. 10.1016/j.actbio.2011.09.03810.1016/j.actbio.2011.09.038 ↗
32. 10.1002/adma.20140155010.1002/adma.201401550 ↗
33. 10.1002/adhm.20130051210.1002/adhm.201300512 ↗
34. Schwartzentruber D. J. · N. Engl. J. Med. · 2011 · 364 · 211910.1056/NEJMoa1012863 ↗
35. 10.1016/j.vaccine.2008.07.03510.1016/j.vaccine.2008.07.035 ↗
36. Hu C.-M. J. · Proc. Natl. Acad. Sci. U. S. A. · 2011 · 108 · 1098010.1073/pnas.1106634108 ↗
37. 10.2147/IJN.S12601610.2147/IJN.S126016 ↗
38. Rao L. · Adv. Funct. Mater. · 2017 · 27 · 160477410.1002/adfm.201604774 ↗
39. 10.1002/smll.20160062410.1002/smll.201600624 ↗
40. 10.1016/j.biomaterials.2017.07.02610.1016/j.biomaterials.2017.07.026 ↗
41. 10.1016/j.actbio.2016.07.01210.1016/j.actbio.2016.07.012 ↗
42. 10.1021/acsnano.6b0469510.1021/acsnano.6b04695 ↗
43. 10.1021/acsami.7b1702210.1021/acsami.7b17022 ↗
44. 10.1021/acsnano.8b0406610.1021/acsnano.8b04066 ↗
45. 10.1002/smll.20180410510.1002/smll.201804105 ↗
46. 10.1002/adfm.20190567110.1002/adfm.201905671 ↗
47. 10.1002/adfm.20190339110.1002/adfm.201903391 ↗
48. Glinsky V. V. · Cancer Res. · 2003 · 63 · 3805
49. 10.1038/nnano.2012.21210.1038/nnano.2012.212 ↗
50. 10.1016/j.biomaterials.2017.07.02710.1016/j.biomaterials.2017.07.027 ↗